Long-term medical outcomes in survivors of extra-ocular retinoblastoma: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Pediatric Blood and Cancer

Volumn 60, Issue 4, 2013, Pages 694-699

  Friedman, Danielle Novetsky ^a   Sklar, Charles A ^a   Oeffinger, Kevin C ^a   Kernan, Nancy A ^a   Khakoo, Yasmin ^a   Marr, Brian P ^a   Wolden, Suzanne L ^a   Abramson, David H ^a   Dunkel, Ira J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Long term effects; Retinoblastoma; Second malignancy; Survivors

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GROWTH HORMONE; LEVOTHYROXINE; RETINOBLASTOMA PROTEIN; THIOTEPA; TOPOTECAN; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CATARACT; CHILDHOOD CANCER; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXTERNAL BEAM RADIOTHERAPY; EXTRAOCULAR RETINOBLASTOMA; FEMALE; GROWTH HORMONE DEFICIENCY; HEARING IMPAIRMENT; HEART DISEASE; HEPATOBILIARY DISEASE; HUMAN; HYPOTHYROIDISM; KIDNEY DISEASE; LEG LENGTH INEQUALITY; LIMB DEFECT; MALE; METASTASIS; OTOTOXICITY; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SHORT STATURE; SIDE EFFECT; VISUAL IMPAIRMENT;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; ENDOCRINE SYSTEM DISEASES; FEMALE; HEARING LOSS; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVORS; TREATMENT OUTCOME; VISION DISORDERS;

EID: 84873722987     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24280     Document Type: Article

References (23)

1. Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, et al. Extraocular retinoblastoma: A 13-year experience. Cancer 2003; 98: 1292-1298.
2. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000; 89: 2117-2121.
3. Dunkel IJ, Chan HS, Jubran R, et al. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer 2010; 55: 149-152.
4. Kremens B, Wieland R, Reinhard H, et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003; 31: 281-284.
5. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003; 110: 1237-1240.
6. Jubran RF, Erdreich-Epstein A, Butturini A, et al. Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. J Pediatr Hematol Oncol 2004; 26: 31-34.
7. American National Standards Institute. Common terminology criteria for adverse events (CTCAE): Version 4.0. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5×7.pdf. Accessed December 1, 2011.
8. Clinical Growth Charts US Center for Disease Control and Prevention, National Center for Health Statistics. http://www.cdc.gov/growthcharts. Accessed December 30, 2011.
9. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60.
10. Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers (including Appendices, Materials for Clinical Application, and Health Links). http://www.survivorshipguidelines.org. Accessed April 1, 2012.
11. Kramer K, Humm JL, Souweidane MM, et al. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. J Clin Oncol 2007; 25: 5465-5470.
12. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
13. Chantada GL, Guitter MR, Fandiño AC, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer 2009; 52: 218-222.
14. van Dijk J, Oostrom KJ, Huisman J, et al. Restrictions in daily life after retinoblastoma from the perspective of the survivors. Pediatr Blood Cancer 2010; 54: 110-115.
15. van Dijk J, Imhof SM, Moll AC, et al. Quality of life of adult retinoblastoma survivors in the Netherlands. Health Qual Life Outcomes 2007; 5: 30.
16. Weintraub N, Rot I, Shoshani N, et al. Participation in daily activities and quality of life in survivors of retinoblastoma. Pediatr Blood Cancer 2011; 56: 590-594.
17. Grewal S, Merchant T, Reymond R, et al. Auditory late effects of childhood cancer therapy: A report from the Children's Oncology Group. Pediatrics 2010; 125: e938-50.
18. Qaddoumi I, Bass JK, Wu J, et al. Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol 2012; 30: 1034-1041.
19. Leahey A. A cautionary tale: Dosing chemotherapy in infants with retinoblastoma. J Clin Oncol 2012; 30: 1023-1024.
20. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 2008; 100: 1771-1779.
21. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001; 108: 1868-1876.
22. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005; 23: 2272-2279.
23. Villani A, Tabori U, Schiffman J, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 2011; 12: 559-567.